Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT – Get Free Report) saw a significant decrease in short interest in October. As of October 15th, there was short interest totaling 67,594 shares, a decrease of 41.3% from the September 30th total of 115,090 shares. Currently, 0.1% of the company’s shares are short sold. Based on an average trading volume of 3,118,131 shares, the days-to-cover ratio is currently 0.0 days.
Zhengye Biotechnology Trading Down 1.9%
NASDAQ:ZYBT traded down $0.03 on Monday, hitting $1.27. The stock had a trading volume of 7,826 shares, compared to its average volume of 1,816,663. The business’s 50-day simple moving average is $1.48 and its two-hundred day simple moving average is $1.16. Zhengye Biotechnology has a 52-week low of $0.62 and a 52-week high of $8.01.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings restated a “sell (d)” rating on shares of Zhengye Biotechnology in a research note on Friday, October 16th. One research analyst has rated the stock with a Sell rating. According to MarketBeat.com, Zhengye Biotechnology has a consensus rating of “Sell”.
Zhengye Biotechnology Company Profile
Zhengye Biotechnology Group Co, Ltd. is a China-based biotechnology company focused on developing, manufacturing and selling biological products for the agricultural and animal husbandry industries. Its business is centered on applying microbial technologies to support animal health, livestock production and crop cultivation.
The company’s product offerings include microbial-based products used in animal feed and agricultural production, as well as related biological solutions intended to improve farming efficiency and promote healthier livestock and crops.
See Also
- Five stocks we like better than Zhengye Biotechnology
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AIāThese 5 Stocks Are Getting Paid
Receive News & Ratings for Zhengye Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zhengye Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
